About Bayer

Bayer Group

Bayer is a global enterprise with core competencies in the fields of healthcare, nutrition and high-tech materials. Our products and services are designed to benefit people and improve their quality of life. At the same time we want to create value through innovation, growth and high earning power.
The Group is committed to the principles of sustainable development and to its role as a socially and ethically responsible corporate citizen. Economy, ecology and social responsibility are corporate policy objectives of equal rank. In fiscal 2010, Bayer employed 111,400 people and had sales of €35.1 billion. Capital expenditures amounted to €1.6 billion, R&D expenses to €3.1 billion.

바이엘 그룹 Products Bayer Group Key Data

Organization

Bayer AG defines common values, goals and strategies for the entire Group. The three subgroups and three service companies operate independently, led by the management holding company. The Corporate Center supports the Group Management Board in its task of strategic leadership

Corporate Governance

Dual governance system with the following govemance bodies:

Board of Management Supervisory Board
four members, Chairman: Dr. Marijn Dekkers 21 members, Chairman: Dr. Manfred Schneider

Products

The Bayer Group markets some 5,000 products. Best-sellers include:

in the health care field in the nutrition field in the field of high-tech materials
Yasmin®/YAZ®/Betaferon®
/KogenateFs®/Adalat®/Avelox®		 Confidor®/Gaucho®/Admire®
/Merit®,Flint®/Stratego®/Sphere®
/Nativo®		 Makrolon®, Bayblend®, BaySystems®, Desmodur®, Desmophen®

Locations

Bayer is represented around the world by about 300 companies*. Global headquarters are in Leverkusen, Germany.

Workforce

Fully consolidated subsidiaries (as of Dec. 31, 2010)

상단으로

Bayer Group Key Data

Bayer Group 2009
€ million		 2010
€ million		 Change
%
Sales 31.168 35.088 12.6
EDITDA1 5.815 6.286 8.1
EBITDA before special items 6.472 7.101 9.7
EBIT2 3.006 2.730 -9.2
EBIT before special items 3.772 4.452 18.0
Income before income taxes 1.870 1.721 -8.0
Net income 1.359 1.301 -4.3
Earnings per share (in€)3 1.70 1.57 -7.6
Gross cash flow4 4.658 4.771 2.4
Net cash flow5 5.375 5.773 7.4
Capital expenditures as per segment table 1.669 1.621 -2.9
Research and deverlopment expenses 2.746 3.053 11.2
Dividend per Bayer AG share (€) 1.40 1.50 7.1

Sales by Segment, (2009 in parentheses)

Reconciliation 3.4% (3.7%)

28.9% (24.1%)

MaterialSciense

19.5% (20.9%)
CropScience

Environmental Science.
BioScience 3.8% (3.5%)
Crop Protection 15.7% (17.4%)

48.2% (51.3%)
HealthCare

Pharmaceutical 30.7% (33.6%)
Consumer Health 17.1% (17.7%)

상단으로

Podcast Center